Quest Diagnostics Reports Fourth Quarter And Full Year 2017 Financial Results; Provides Guidance For Full Year 2018; Increases Dividend 11% To $0.50 Per Quarter

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. GOOGL
6. APGE
7. DFTX
8. MU
9. IBM
10. HOOD

Go back to Quest Diagnostics Reports Fourth Quarter And Full Year 2017 Financial Results; Provides Guidance For Full Year 2018; Increases Dividend 11% To $0.50 Per Quarter

Credit Suisse Assumes Quest Diagnostics (DGX) at Neutral

February 2, 2018 7:28 AM EST

Credit Suisse assumes coverage on Quest Diagnostics (NYSE: DGX) with a Neutral rating and a price target of $107.00.

A.J. Rice is the new analyst covering the stock.

For an analyst ratings summary and ratings history on Quest Diagnostics... More

Quest Diagnostics (DGX) Tops Q4 EPS by 2c, Offers Guidance

February 1, 2018 6:46 AM EST

Quest Diagnostics (NYSE: DGX) reported Q4 EPS of $1.40, $0.02 better than the analyst estimate of $1.38. Revenue for the quarter came in at $1.94 billion versus the consensus estimate of $1.94 billion.

GUIDANCE:

Quest Diagnostics sees FY2018 EPS of $6.50-$6.70, versus the consensus of... More